Company also provides update on potential U.S. listing CHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance…


Previous articleCaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development
Next articleHamilton Morris joins COMPASS Pathways to research new psychedelic compounds